Description
Irbetan-N Tablets 300 mg/12.5 mg. #30
Description:
Irbetan-N tablets are a combination medication containing 300 mg. of irbesartan and 12.5 mg. of hydrochlorothiazide. This medication is commonly prescribed to treat high blood pressure (hypertension) in adults. The active ingredients in Irbetan-N work together to help lower blood pressure by relaxing blood vessels and increasing urine output to reduce fluid retention.
Indications:
Irbetan-N tablets are indicated for the treatment of hypertension in patients who require both irbesartan and hydrochlorothiazide for optimal blood pressure control. This medication is typically prescribed when monotherapy with either irbesartan or hydrochlorothiazide alone is not sufficient to control blood pressure.
Dosage and Administration:
The usual recommended dose of Irbetan-N is one tablet once daily. The tablets should be taken with a full glass of water and can be taken with or without food. It is important to take the medication consistently at the same time each day to maintain steady blood levels of the active ingredients.
Contraindications:
Irbetan-N tablets are contraindicated in patients with a known hypersensitivity to any component of the medication, including irbesartan, hydrochlorothiazide, or other sulfonamide-derived drugs. This medication should not be used in patients with anuria (no urine production) or severe renal impairment.
Adverse Effects:
Common side effects of Irbetan-N may include dizziness, headache, fatigue, and changes in urination frequency. More serious side effects such as allergic reactions, electrolyte imbalances, or kidney problems may occur in some patients. It is important to notify your healthcare provider if you experience any concerning symptoms while taking this medication.
Drug Interactions:
Irbetan-N may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), lithium, potassium-sparing diuretics, and other antihypertensive agents. It is important to inform your healthcare provider of all medications you are taking, including over-the-counter drugs and herbal supplements, to avoid potential drug interactions.
Storage:
Irbetan-N tablets should be stored at room temperature away from moisture and heat. Keep the medication in its original packaging and out of reach of children and pets. Do not use the medication past its expiration date and dispose of any unused tablets properly according to local regulations.
Warnings and Precautions:
Before starting Irbetan-N, inform your healthcare provider if you have a history of kidney or liver disease, electrolyte imbalances, diabetes, or if you are pregnant or breastfeeding. This medication may affect blood sugar levels, so monitoring blood glucose regularly is recommended for diabetic patients.
Overdose:
In case of an overdose of Irbetan-N, seek immediate medical attention or contact a poison control center. Symptoms of overdose may include dizziness, fainting, rapid or irregular heartbeat, and electrolyte imbalances. Do not attempt to self-treat an overdose of this medication.
Conclusion:
Irbetan-N tablets are a combination medication used in the treatment of hypertension. By combining irbesartan and hydrochlorothiazide, this medication helps lower blood pressure and reduce the risk of cardiovascular events. It is important to take this medication as prescribed and to follow up with your healthcare provider regularly to monitor your blood pressure and overall health.
